Accumulating evidence indicates that IL-17 directly communicates with the Jak/Stat and PI3K/Akt signalling pathways and that it also targets NF-kB, AP-1 and Sp1 in many tumour types12, 36. This evidence concerns the gene AKT1 and neoplasm.